Newsletter Subject

Will The Faceless Monster Bring Havoc to Wall Street?

From

eaglefinancialpublications.com

Email Address

financial@mail.eaglefinancialpublications.com

Sent On

Fri, Aug 2, 2024 01:01 PM

Email Preheader Text

This time the “game-changer” really does change the game! to check out the latest news?

This time the “game-changer” really does change the game! [Eagle Financial Publications] Below please find a special message from one of our sponsors, Healwell. From time to time we find special opportunities we believe you as a valued customer may want to see. Please note that the following message reflects the opinions and representations of our sponsor alone, and not necessarily the opinion or editorial positions of Eagle Financial Publications or Salem Communications. Fellow Investor, A friend calls it the “Faceless Monster.” Some say it will cause millions of lost jobs. Others say it will change the face of most industries. Others fear the security risks it brings into every home and office. You know this monster as AI – Artificial Intelligence. But there is one industry – and one company in that industry – that seems to have cracked the code to not only tackle the Monster but use it to the benefit of every person on the planet! This company discovered how to tame AI and use it in one of the fastest growing – and most vital industries: healthcare. Yes, by 2030, healthcare will be a $10+ trillion-dollar industry. And now is the time for investors to seriously examine how the tamed beast of AI and healthcare make a perfect investment opportunity. [Click here now]( to check out the latest news… Sincerely, [Jim Woods] Jim Woods Editor, Successful Investing [Download Free Report]( IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of HealWELL AI Inc. (“HealWELL”; OTCQX: HWAIF). This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities of HealWELL. In an effort to enhance public awareness, HealWELL is the sole source of funds for a budget of approximately $1,001,180 to cover the costs associated with creating and distribution of this advertisement. In accordance with Section 17(b) of the U.S. Securities Act of 1933, Eagle Products, LLC hereby discloses that HealWELL paid it $55,000 as a research fee. The advertising agencies will retain any excess sums after all expenses are paid. While this advertisement is being disseminated and for a period of not less than 90 days thereafter, Eagle Products, LLC, the advertising agencies, and their respective officers, principals, or affiliates will not trade in securities of HealWELL. If successful, this advertisement will increase investor and market awareness of HealWELL and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, the advertising agencies and Eagle Products, LLC do not purport to provide a complete analysis of HealWELL or its financial position. The advertising agencies and Eagle Products, LLC are not, and do not purport to be, broker-dealers or investment advisers, as defined under any applicable jurisdiction’s securities laws. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a broker-dealer or investment adviser or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about HealWELL. Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in the latest HealWELL Annual Information Form dated April 1, 2024 which is available at www.sedarplus.com. Investing in microcap securities such as HealWELL is speculative and carries a high degree of risk. Past performance may not be indicative of and does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Eagle Products, LLC cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains “forward-looking information” and “forward-looking statements within the meaning of applicable securities laws, which are based on assumptions, estimates and projections as of the date of this advertisement, including statements regarding expected growth of HealWELL and/or its industry, potential synergies between HealWELL’s various product and service offerings, and HealWELL’s intention to leverage AI capabilities and expertise to expand and grow. Such statements and information are often, but not always, accompanied by words or phrases such as “future”, “potential”, “expect”, “intend”, “plan”, “anticipate”, “continues to”, “is becoming”, or variations of such words and phrases or statements that certain future conditions, actions, events or results “will”, “may”, “could”, “would”, “should”, “might” or “can” be taken, occur or be achieved, or the negative of any of these terms. The advertising agencies and Eagle Products, LLC note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect HealWELL’s actual results of operations. Factors that could cause actual results to vary include: the size and growth of the market for HealWELL’s products and/or services, the company’s ability to fund its capital requirements in the near term and long term, federal, state and provincial regulatory issues in the jurisdictions where the company operates or intends in the future to operate, pricing pressures; HealWELL’s ability to identify potential M&A partners and acquisition targets and successfully complete accretive transactions; HealWELL’s ability to successfully integrate its acquisition targets; developments in AI, data management, clinical research and other industries in which HealWELL operates; trends in customer growth; the need for increasingly innovating products and services; competition in the industry; customers adopting and using new technologies and services as expected; new technologies functioning as expected; anticipated development timelines for new products and services, or to expand existing product and service offerings into new jurisdictions; etc. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The advertising agencies and Eagle Products, LLC disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward looking statements, except to the extent required by applicable law. This advertisement contains future-oriented financial information and financial outlook information (collectively, “FOFI”) about HealWELL’s expected increase in revenue, cash flow, profitability, profit margins, etc., all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraphs. The actual financial results of HealWELL may vary from the amounts set out herein and such variation may be material. The advertising agencies and Eagle Products, LLC believe that the FOFI has been prepared on a reasonable basis, reflecting management’s best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, the advertising agencies and Eagle Products, LLC undertake no obligation to update such FOFI. FOFI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about HealWELL’s anticipated future business operations. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein. All trademarks used in this advertisement other than Eagle Products, LLC are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Eagle Products, LLC are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks. To ensure future delivery of Eagle Financial Publication's emails please add the domain @mail.eaglefinancialpublications.com to your address book or contact list. This email was sent to {EMAIL} because you are subscribed to the Carefully Selected Financial Offers from Third Parties List. To unsubscribe please click [here](. To stop receiving emails simply click [here](. View this email in your [web browser](. If you have questions, please send them to [Customer Service](mailto:customerservice@eaglefinancialpublications.com). Eagle Financial Publications - Eagle Products, LLC. - a Salem Communications Holding Company 122 C Street NW, Suite 515 | Washington, D.C. 20001 © Eagle Financial Publications. All rights reserved. [Link](

Marketing emails from eaglefinancialpublications.com

View More
Sent On

16/10/2024

Sent On

16/10/2024

Sent On

16/10/2024

Sent On

13/10/2024

Sent On

12/10/2024

Sent On

12/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.